Current Oncology Reports

Article	Citations
COVID-19 and Cancer: a Comprehensive Review	195
Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?	136
Clinical and Biological Features of Neuroendocrine Prostate Cancer	112
Update on Osteosarcoma	95
Targeting Apoptosis in Cancer	71
Update on Management of Squamous Cell Esophageal Cancer	71
Proteasome Inhibitor-Related Cardiotoxicity: Mechanisms, Diagnosis, and Management	57
Cardiotoxicity of Immune Checkpoint Inhibitors	56
Immunotherapy for Non-melanoma Skin Cancer	51
The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites	50
Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors	49
New Insights into Mechanisms of Immune Checkpoint Inhibitor-Induced Cardiovascular Toxicity	45
Immunotherapy in Cervical Cancer	44
Determination of Biological Age: Geriatric Assessment vs Biological Biomarkers	43
WEE1 Inhibitor: Clinical Development	39
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors	38
The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines)	38
Bystander effect of antibody–drug conjugates: fact or fiction?	37
Giant Cell Tumor of Bone: An Update	36
Psychological Aspects to Consider in Breast Cancer Diagnosis and Treatment	34
Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers	34
VEGF Receptor Inhibitor-Induced Hypertension: Emerging Mechanisms and Clinical Implications	33
A Review of the Current State of Hospice Care in China	33
Biological and Functional Biomarkers of Aging: Definition, Characteristics, and How They Can Impact Everyday Cancer Treatment	33
Acute Myeloid Leukemia in Children: Emerging Paradigms in Genetics and New Approaches to Therapy	32

Post-Diagnostic Dietary and Lifestyle Factors and Prostate Cancer Recurrence, Progression, and Mortality	32
Ependymoma: Evaluation and Management Updates	32
The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities	30
Cognitive Behavioral and Mindfulness-Based Interventions for Smoking Cessation: a Review of the Recent Literature	30
First-Line Management of Advanced High-Grade Serous Ovarian Cancer	29
Emerging Therapeutics for Patients with Triple-Negative Breast Cancer	28
The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population	28
Application of PET Tracers in Molecular Imaging for Breast Cancer	27
Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies	27
Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics	27
ROS1 Targeted Therapies: Current Status	27
Management of Pigmented Villonodular Synovitis (PVNS): an Orthopedic Surgeon’s Perspective	26
Present and Future of De-intensification Strategies in the Treatment of Oropharyngeal Carcinoma	26
Disparities in Lung Cancer Treatment	26
Current Advances in Immunotherapy for Glioblastoma	25
Sequencing Endocrine Therapy for Metastatic Breast Cancer: What Do We Do After Disease Progression on a CDK4/6 Inhibitor?	25
Targeting KRAS in Colorectal Cancer	25
The Treatment Landscape of Advanced Hepatocellular Carcinoma	24
Fatty Acid Metabolism and Cancer Immunotherapy	24
Improving the Safety of Major Resection for Hepatobiliary Malignancy: Portal Vein Embolization and Recent Innovations in Liver Regeneration Strategies	24
Vitamin D and Cancer Survival: Does Vitamin D Supplementation Improve the Survival of Patients with Cancer?	24
FGFR Inhibitors: Clinical Activity and Development in the Treatment of Cholangiocarcinoma	24
Anti-angiogenesis Revisited: Combination with Immunotherapy in Solid Tumors	24
Multidisciplinary Outpatient Cancer Rehabilitation Can Improve Cancer Patients’ Physical and Psychosocial Status—a Systematic Review	23
COVID and Lung Cancer	23
CAR-T Therapies in Solid Tumors: Opportunities and Challenges	23
Engineered T Cells: CAR T Cell Therapy and Beyond	23
Bruton’s tyrosine kinase Inhibitors and Cardiotoxicity: More Than Just Atrial Fibrillation	23
Checkpoint Inhibitor Pneumonitis: Mechanisms, Characteristics, Management Strategies, and Beyond	22
Mixed Phenotype Acute Leukemia: Current Approaches to Diagnosis and Treatment	22
Prostate Cancer Immunotherapy—Finally in From the Cold?	22
New Checkpoint Inhibitors on the Road: Targeting TIM-3 in Solid Tumors	22
Identifying and Meeting the Needs of Adolescents and Young Adults with Cancer	21
Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3–5 cm) Unresectable Colorectal Liver Metastases: a System	20
Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and Management	20
Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues	20
Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer	20
Surgical Approach to Lymphedema Reduction	19
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications	19
The Development of STING Agonists and Emerging Results as a Cancer Immunotherapy	18
Richter Syndrome	18
Role of Platinums in Triple-Negative Breast Cancer	18
Chemotherapy and Radiation-Associated Cardiac Autonomic Dysfunction	18
Neutrophil Extracellular Trapping Role in Cancer, Metastases, and Cancer-Related Thrombosis: a Narrative Review of the Current Evidence Base	18
Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs	18
The Role of Malnutrition and Muscle Wasting in Advanced Lung Cancer	18
Telemedicine in Cancer Care Beyond the COVID-19 Pandemic: Oncology 2.0?	18
Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions	17
Desmoid Fibromatosis: Management in an Era of Increasing Options	17
The Management of rNPC: Salvage Surgery vs. Re-irradiation	17

Cytokines in the Treatment of Melanoma	17
Diagnostic and Therapeutic Considerations for Extramedullary Leukemia	16
Advances in Molecular Classification and Therapeutic Opportunities in Meningiomas	16
Management of the Small Renal Mass: a 2020 Update	16
COVID-19 in Children with Cancer	16
Cancer Pain Management—New Therapies	16
Updates in Cardiac Amyloidosis Diagnosis and Treatment	16
Cancer Screening Among Older Adults: a Geriatrician’s Perspective on Breast, Cervical, Colon, Prostate, and Lung Cancer Screening	16
IDH-Mutant Low-grade Glioma: Advances in Molecular Diagnosis, Management, and Future Directions	16
DNA Repair Mechanisms and Therapeutic Targets in Glioma	16
Neurological Complications of CAR T Cell Therapy	15
Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment	15
Management of Acute Myeloid Leukemia (AML) in Older Patients	15
Progress Update in Pediatric Renal Tumors	15
Management of the Neck in Well-Differentiated Thyroid Cancer	15
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?	15
Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature	15
Molecular Subgroups of Diffuse Large B Cell Lymphoma: Biology and Implications for Clinical Practice	15
Neurofibromatosis in the Era of Precision Medicine: Development of MEK Inhibitors and Recent Successes with Selumetinib	15
Clinical Development of Anti-TIGIT Antibodies for Immunotherapy of Cancer	15
Current Clinical Trial Landscape of OX40 Agonists	15
Current Approaches in Hepatoblastoma—New Biological Insights to Inform Therapy	15
Radiogenomics in Interventional Oncology	15
Role of Machine Learning and Artificial Intelligence in Interventional Oncology	14
Approaches to Non-Muscle-Invasive Bladder Cancer	14
Rare Breast Cancer Subtypes	14
Neuroendocrine Tumors: a Relevant Clinical Update	14
Radiation Therapy and Mandibular Osteoradionecrosis: State of the Art	14
State of Rehabilitation Research in the Head and Neck Cancer Population: Functional Impact vs. Impairment-Focused Outcomes	14
Management of Upper Tract Urothelial Carcinoma	14
Review of New-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia	14
Palliative and End-of-Life Care for Sexual and Gender Minority Cancer Survivors: a Review of Current Research and Recommendations	14
Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities	14
Interventions that Facilitate Shared Decision-Making in Cancers with Active Surveillance as Treatment Option: a Systematic Review of Literature	14
Global Perspectives on Palliative Care for Cancer Patients: Not All Countries Are the Same	14
Is There a Role for Percutaneous Ablation for Early Stage Lung Cancer? What Is the Evidence?	13
Value and Quality of Care in Head and Neck Oncology	13
Updates on Surgical Management and Advances for Brain Tumors	13
The Evolving Role of Radiation Therapy in Patients with Metastatic Soft Tissue Sarcoma	13
Global Perceptions of Women on Breast Cancer and Barriers to Screening	13
Immune Checkpoint Inhibitor Rechallenge and Resumption: a Systematic Review	13
Cancer-Related Fatigue—Is There a Role for Complementary and Integrative Medicine?	13
CAR T-Cell Therapy in the Older Person: Indications and Risks	13
Acute Leukemia in Infants	12
Mitochondrial Inhibition: a Treatment Strategy in Cancer?	12
Medulloblastoma: an Old Diagnosis with New Promises	12
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?	12
Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation?	12
A New Generation of Vaccines in the Age of Immunotherapy	12
Isocitrate Dehydrogenase, Patient-Reported Outcomes, and Cognitive Functioning of Glioma Patients: a Systematic Review	12
The Role and Impact of Minimal Residual Disease in NSCLC	12
The Combined Use of SBRT and Immunotherapy—a Literature Review	12
Lymphoblastic Lymphoma: a Concise Review	12
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications	12
Locally Advanced Pancreatic Cancer: Percutaneous Management Using Ablation, Brachytherapy, Intra-arterial Chemotherapy, and Intra-tumoral Immunotherapy	12
Older Patients with Acute Myeloid Leukemia Deserve Individualized Treatment	12
Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment	12
Current Role of Functional Imaging in the Management of Lymphoma	11
AXL Inhibitors: Status of Clinical Development	11
Immunology of Lynch Syndrome	11
Racial Disparity in Response to Prostate Cancer Systemic Therapies	11
What Do We Currently Know About Chronic Myeloid Leukemia (CML) and COVID-19?	11
Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building	11
Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients	11
What’s New in Percutaneous Ablative Strategies for Hepatocellular Carcinoma and Colorectal Hepatic Metastases? 2020 Update	11
Induction Chemotherapy for Advanced Oral Cavity Cancer	11
Triplet Therapy in Melanoma — Combined BRAF/MEK Inhibitors and Anti-PD-(L)1 Antibodies	11
Radiotherapy and Immunotherapy Combinations for Lung Cancer	11
Palliative Care in Paediatric Oncology: an Update	11
Alternative Checkpoints as Targets for Immunotherapy	11
Vitamin D in Head and Neck Cancer: a Systematic Review	11
Prehabilitative Exercise for the Enhancement of Physical, Psychosocial, and Biological Outcomes Among Patients Diagnosed with Cancer	11
Improving Breast Cancer Responses to Immunotherapy—a Search for the Achilles Heel of the Tumor Microenvironment	11
Striving toward Improved Outcomes for Surgically Resectable Non-Small Cell Lung Cancer: the Promise and Challenges of Neoadjuvant Immunotherapy	10
Advances in the Management of Pediatric Sarcomas	10
Thermal Ablation for the Management of Papillary Thyroid Microcarcinoma in the Era of Active Surveillance and Hemithyroidectomy	10
Novel Approaches to the Systemic Management of Uveal Melanoma	10
Spectrum and Clinical Activity of PD-1/PD-L1 Inhibitors: Regulatory Approval and Under Development	10
Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate Cancer	10
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications	10

Dendritic Cell Leukemia: a Review	10
Microtubule Inhibitors and Cardiotoxicity	10
Combined Inhibition of EGFR and VEGF Pathways in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis	10
Chemotherapy in Cutaneous Melanoma: Is There Still a Role?	10
Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology	10
The Concept of Respite in Palliative Care: Definitions and Discussions	10
Cardiovascular Toxicities of CAR T-cell Therapy	10
Perioperative NSAIDs and Long-Term Outcomes After cancer Surgery: a Systematic Review and Meta-analysis	10
BTK Inhibitors and CAR T-Cell Therapy in Treating Mantle Cell Lymphoma—Finding a Dancing Partner	10
Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer	10
The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients	10
New Treatments for Recurrent Uterine Cancer	10
Antibiotic Management of Patients with Hematologic Malignancies: From Prophylaxis to Unusual Infections	10
Effects of Yoga-Based Interventions on Cancer-Associated Cognitive Decline: a Systematic Review	10